Genetic and epidemiological factors for age-related traits and diseases in the sardinian population (SARDINIA5); period of performance: june 1, 2021 - may 31, 2026
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95021C00012
- Awardee
-
Consiglio Nazionale Delle Ricerche - Istituto DI Ricerca Genetica E Biomedica UEI SHGLP4KLBQN6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,327,587
Award facts
- Opportunity
-
- 75N95021R00009 Solicitation number
- Contract value 100% obligated
- $6,327,587.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Italy
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,081,347 | |
| Funding Only Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $11,408,934 |
About this award
The National Institute on Aging awarded a definitive contract to Consiglio Nazionale Delle Ricerche - Istituto DI Ricerca Genetica E Biomedica on June 1, 2021, for genetic and epidemiological factors for age-related traits and diseases in the Sardinian population (SARDINIA5), with a ceiling value of $6.33 million and ultimate completion date of September 30, 2026.
The contract is priced as cost no fee and carries no set-aside. Place of performance is Italy.
In fiscal year 2024, the most recent reported period, the contract invoked 7.5 FTEs across 15,522 contractor hours at a derived government-paid hourly rate of $27.61 per hour. The prime self-performed all reported hours with no subcontractors. The fiscal year 2024 invoiced amount was $429 thousand. Across the three reported fiscal years (FY2022–FY2024), the derived hourly rate declined from $197.89 per hour in FY2022 to $22.78 per hour in FY2023, stabilizing at $27.61 in FY2024.
Quick answers
Who was awarded contract 75N95021C00012?
75N95021C00012 was awarded to Consiglio Nazionale Delle Ricerche - Istituto DI Ricerca Genetica E Biomedica by National Institute on Drug Abuse (National Institutes of Health) on June 1, 2021.
How much is contract 75N95021C00012 worth?
The government has obligated $6,327,587 on 75N95021C00012.
Which agency awarded contract 75N95021C00012?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021C00012, with funding from National Institute on Aging (National Institutes of Health).
Was contract 75N95021C00012 competed?
The extent of competition for 75N95021C00012 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award